Protease inhibitors and erectile dysfunction.
Sollima
S
S
Institute of Infectious and Tropical Diseases, University of Milan, Italy.
Osio
M
M
Muscia
F
F
Gambaro
P
P
Alciati
A
A
Zucconi
M
M
Maga
T
T
Adorni
F
F
Bini
T
T
d'Arminio Monforte
A
A
D000293:Adolescent; D000328:Adult; D007172:Erectile Dysfunction / Q000139:chemically induced*; D015658:HIV Infections / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006728:Hormones / Q000097:blood; D006801:Humans; D019469:Indinavir / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000187:drug effects; D017933:Peripheral Nervous System / Q000187:drug effects* / Q000503:physiopathology; D011237:Predictive Value of Tests; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011795:Surveys and Questionnaires
D017320:HIV Protease Inhibitors; D006728:Hormones; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir